The Recall Desk
Agency classClass IOur severity:SevereFDA (Devices)·Z-0003-2025·Announced 2024-10-09

MiniMed Insulin Pumps May Stop Delivering Insulin After Physical Impact

Medtronic MiniMed insulin pumps (670G, 770G, 780G) that have been dropped or bumped may develop internal battery defects causing premature failure and interrupted insulin delivery, risking dangerously high blood sugar.

The agency’s classification

FDA (Devices): Class I

Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 4/5 (Severe).

The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: This is an FDA Class I recall, which requires a minimum severity score of 4. While the defect can lead to serious consequences including diabetic ketoacidosis, no deaths or injuries have been reported in the source text. The documented physical defect and clear pathway to serious harm justify a Severe classification.

Plain-English summary

Medtronic MiniMed, Inc. is recalling 526,558 MiniMed insulin pumps (models 670G, 770G, and 780G) distributed in the United States and worldwide. These pumps may be affected if they have been dropped, bumped, or physically impacted.

Physical impact can cause internal electrical components to become damaged, resulting in premature battery failure. Affected pumps experience shortened battery life with reduced time between low battery warnings. The final low battery alarm may sound much closer to actual power loss—potentially only 2.5 hours before the pump shuts down, rather than the designed 10-hour warning buffer. Replacing the battery will not resolve the underlying defect; the shortened battery life will continue to occur.

If an affected pump loses power unexpectedly, insulin delivery stops immediately. Interrupted insulin delivery can result in insufficient insulin in the body, potentially leading to hyperglycemia or diabetic ketoacidosis (DKA). Both conditions can be serious if not promptly addressed.

The recalled product

Product
MiniMed Insulin Pump Device. MiniMed 670G, REF: MMT-1580, MMT-1581, MMT-1582, MMT-1780, MMT-1781, MMT-1782, MMT-1740, MMT-1741, MMT-1742, MMT-1760, MMT-1761, MMT-1762; MiniMed 770G, REF: MMT-1880, MMT-1881, MMT-1882, MMT-1890, MMT-1891, MMT-1892; MiniMed 780G, REF: MMT-1884…
Manufacturer
Medtronic MiniMed, Inc.
Category
Medical Device — Insulin Pump
Hazard
Affected units
526,558

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (20)

  • REF/UDI-DI(GTIN): MMT-1780/00763000190453
  • 00643169946057
  • 00763000365882
  • 00763000096984
  • 00763000283445
  • 763000283513
  • 763000283506
  • 763000365882
  • 763000283520
  • 76300028351303
  • 763000393786
  • 763000166526
  • 76300028351301
  • 643169939202
  • 763000190460
  • 763000090203
  • 763000256821
  • 643169939219
  • 763000072537
  • 763000365912

Distribution

Distributed in 53 states:

Part of a larger recall action

This product is one of 3 recalled by Medtronic MiniMed, Inc. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 3 products in this recall →

Related recalls

Same manufacturer · Medtronic MiniMed, Inc.

See all →

Same hazard · battery failure

See all →

Similar recalls